﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/wockhardt-submits-nda-to-usfda-for-zidebactam-cefepime-injection-17932</loc><lastmod>2025-10-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fda-approves-roches-tecentriq-lurbinectedin-as-first-line-maintenance-therapy-for-lung-cancer-17933</loc><lastmod>2025-10-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/abbvies-natrelle-awarded-supplier-agreement-from-vizient-17934</loc><lastmod>2025-10-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/bmss-anti-mtbr-tau-granted-fast-track-designation-by-fda-for-alzheimers-disease-17935</loc><lastmod>2025-10-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/takeda-exits-cell-therapy-research-17936</loc><lastmod>2025-10-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/amgens-phase-iii-data-supports-fda-label-expansion-of-repatha-17937</loc><lastmod>2025-10-05T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>